SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE
OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
|
|
Healthcare
IT |
|
|
Medical
Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
|
|
Nine Months Ended September 30, 2023 |
|
|
|
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical
Practice Management |
|
|
Unallocated Corporate Expenses |
|
|
Total |
|
Net revenue |
|
$ |
78,531 |
|
|
$ |
10,112 |
|
|
$ |
- |
|
|
$ |
88,643 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
46,003 |
|
|
|
7,840 |
|
|
|
- |
|
|
|
53,843 |
|
Selling and marketing |
|
|
7,503 |
|
|
|
26 |
|
|
|
- |
|
|
|
7,529 |
|
General and administrative |
|
|
8,466 |
|
|
|
1,362 |
|
|
|
6,690 |
|
|
|
16,518 |
|
Research and development |
|
|
3,523 |
|
|
|
- |
|
|
|
- |
|
|
|
3,523 |
|
Change
in contingent consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
10,013 |
|
|
|
269 |
|
|
|
- |
|
|
|
10,282 |
|
Loss on lease terminations and unoccupied lease charges |
|
|
430 |
|
|
|
-
|
|
|
|
- |
|
|
|
430 |
|
Total operating expenses |
|
|
75,938 |
|
|
|
9,497 |
|
|
|
6,690 |
|
|
|
92,125 |
|
Operating income (loss) |
|
$ |
2,593 |
|
|
$ |
615 |
|
|
$ |
(6,690 |
) |
|
$ |
(3,482 |
) |
|
|
Healthcare
IT |
|
|
Medical
Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
|
|
Three Months Ended September 30, 2023 |
|
|
|
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical
Practice Management |
|
|
Unallocated Corporate
Expenses |
|
|
Total |
|
Net revenue |
|
$ |
25,592 |
|
|
$ |
3,688 |
|
|
$ |
- |
|
|
$ |
29,280 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
15,369 |
|
|
|
2,891 |
|
|
|
- |
|
|
|
18,260 |
|
Selling and marketing |
|
|
2,329 |
|
|
|
8 |
|
|
|
- |
|
|
|
2,337 |
|
General and administrative |
|
|
2,719 |
|
|
|
466 |
|
|
|
2,297 |
|
|
|
5,482 |
|
Research and development |
|
|
1,260 |
|
|
|
- |
|
|
|
- |
|
|
|
1,260 |
|
Change
in contingent consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
3,814 |
|
|
|
89 |
|
|
|
- |
|
|
|
3,903 |
|
Loss on lease terminations and unoccupied lease charges |
|
|
8 |
|
|
|
-
|
|
|
|
- |
|
|
|
8 |
|
Total operating expenses |
|
|
25,499 |
|
|
|
3,454 |
|
|
|
2,297 |
|
|
|
31,250 |
|
Operating income (loss) |
|
$ |
93 |
|
|
$ |
234 |
|
|
$ |
(2,297 |
) |
|
$ |
(1,970 |
) |
|
|
Healthcare
IT |
|
|
Medical
Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
|
|
Nine Months Ended September 30, 2022 |
|
|
|
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical
Practice Management |
|
|
Unallocated Corporate
Expenses |
|
|
Total |
|
Net revenue |
|
$ |
96,146 |
|
|
$ |
10,146 |
|
|
$ |
- |
|
|
$ |
106,292 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
56,878 |
|
|
|
7,988 |
|
|
|
- |
|
|
|
64,866 |
|
Selling and marketing |
|
|
7,293 |
|
|
|
21 |
|
|
|
- |
|
|
|
7,314 |
|
General and administrative |
|
|
10,213 |
|
|
|
1,312 |
|
|
|
6,954 |
|
|
|
18,479 |
|
Research and development |
|
|
3,251 |
|
|
|
- |
|
|
|
- |
|
|
|
3,251 |
|
Change in contingent consideration |
|
|
(2,890 |
) |
|
|
- |
|
|
|
- |
|
|
|
(2,890 |
) |
Depreciation and amortization |
|
|
8,420 |
|
|
|
266 |
|
|
|
- |
|
|
|
8,686 |
|
Net loss on lease terminations and unoccupied lease charges |
|
|
928 |
|
|
|
- |
|
|
|
- |
|
|
|
928 |
|
Total operating expenses |
|
|
84,093 |
|
|
|
9,587 |
|
|
|
6,954 |
|
|
|
100,634 |
|
Operating income (loss) |
|
$ |
12,053 |
|
|
$ |
559 |
|
|
$ |
(6,954 |
) |
|
$ |
5,658 |
|
|
|
Healthcare
IT |
|
|
Medical
Practice
Management |
|
|
Unallocated
Corporate
Expenses |
|
|
Total |
|
|
|
Three Months Ended September 30, 2022 |
|
|
|
($ in thousands) |
|
|
|
Healthcare IT |
|
|
Medical
Practice Management |
|
|
Unallocated Corporate
Expenses |
|
|
Total |
|
Net revenue |
|
$ |
29,964 |
|
|
$ |
3,759 |
|
|
$ |
- |
|
|
$ |
33,723 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating costs |
|
|
17,582 |
|
|
|
2,824 |
|
|
|
- |
|
|
|
20,406 |
|
Selling and marketing |
|
|
2,496 |
|
|
|
8 |
|
|
|
- |
|
|
|
2,504 |
|
General and administrative |
|
|
3,231 |
|
|
|
455 |
|
|
|
2,814 |
|
|
|
6,500 |
|
Research and development |
|
|
1,168 |
|
|
|
- |
|
|
|
- |
|
|
|
1,168 |
|
Change in contingent consideration |
|
|
(1,660 |
) |
|
|
- |
|
|
|
- |
|
|
|
(1,660 |
) |
Depreciation and amortization |
|
|
2,721 |
|
|
|
89 |
|
|
|
- |
|
|
|
2,810 |
|
Net loss on lease terminations and unoccupied lease charges |
|
|
307 |
|
|
|
- |
|
|
|
- |
|
|
|
307 |
|
Total operating expenses |
|
|
25,845 |
|
|
|
3,376 |
|
|
|
2,814 |
|
|
|
32,035 |
|
Operating income (loss) |
|
$ |
4,119 |
|
|
$ |
383 |
|
|
$ |
(2,814 |
) |
|
$ |
1,688 |
|
|